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Background: p-Phenylenediamine (PDA) or its related chemicals are used more extensively 
than oxidative hair dyes. However, permanent hair dyes such as PDA are known to have potent 
contact allergy reactions in humans, and severe allergic reactions are problematic.
Methods: PDA-incorporated nanoparticles were prepared based on ion-complex formation 
between the cationic groups of PDA and the anionic groups of poly(γ-glutamic acid) (PGA). 
To reinforce PDA/PGA ion complexes, glycol chitosan (GC) was added. PDA-incorporated 
nanoparticles were characterized using field-emission scanning electron microscopy, 
  Fourier-transform infrared (FT-IR) spectroscopy, dynamic light scattering, and powder X-ray 
diffractometry (XRD).
Results: Nanoparticles were formed by ion-complex formation between the amine groups 
of PDA and the carboxyl groups of PGA. PDA-incorporated nanoparticles are small in size 
(,100 nm), and morphological observations showed spherical shapes. FT-IR spectra results 
showed that the carboxylic acid peak of PGA decreased with increasing PDA content, indicating 
that the ion complexes were formed between the carboxyl groups of PGA and the amine groups 
of PDA. Furthermore, the intrinsic peak of the carboxyl groups of PGA was also decreased by 
the addition of GC. Intrinsic crystalline peaks of PDA were observed by XRD. This crystalline 
peak of PDA was completely nonexistent when nanoparticles were formed by ion complex 
between PDA, PGA, and GC, indicating that PDA was complexed with PGA and no free drug 
existed in the formulation. During the drug-release experiment, an initial burst release of PDA 
was observed, and then PDA was continuously released over 1 week. Cytotoxicity testing 
against HaCaT human skin keratinocyte cells showed PDA-incorporated nanoparticles had 
lower toxicity than PDA itself. Furthermore, PDA-incorporated nanoparticles showed reduced 
apoptosis and necrosis reaction at HaCaT cells.
Conclusion: The authors suggest that these microparticles are ideal candidates for a vehicle 
for decreasing side effects of hair dye.
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Introduction
In recent decades, permanent hair dyes have received considerable attention due to their 
potent contact allergen p-phenylenediamine (PDA). PDA or its related chemicals are 
used more extensively than oxidative hair dyes. However, hypersensitivity, immune 
response, or severe allergic reactions following hair-dyeing have been reported.1 In 
particular, consumer-available PDA-containing hair dyes are known to be potent 
immune activators that lead to increased inflammatory cytokines.2 Furthermore, PDA 
may cause deoxyribonucleic acid (DNA) cleavage or gene toxicity against human skin 
keratinocyte cells under light irradiation.3 Derivatives of PDA chemicals are known to 
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induce DNA damage and carcinogenic reactions in human 
skin keratinocyte cells.4,5
Nanoparticles have been extensively investigated to attain 
efficient drug delivery to a desired site of action and to control 
drug release for a desired length of time.6,7 Due to their small 
sizes, nanoparticles can be administered via various routes 
such as parenteral, oral, ocular, dermal or transdermal, and 
intranasal inhalation.8–14 Nanoparticles are regarded as ideal 
vehicles for targeted delivery to a specific body site and for 
reduction of unwanted side effects of bioactive agents.7–9 
Particularly, nanoparticles are known to be efficient carriers 
for topical delivery of bioactive agents to the skin and hair.13,14 
Lademann et al reported that dye-containing nanoparticles 
penetrate much deeper into the hair follicles and are stored 
in the hair follicles longer than the nonparticle form.14 Hair 
ingredient-encapsulated nanoparticles are known to enhance 
hair growth.15 Furthermore, the intrinsic small size of nano-
particles is regarded as playing an important role in skin 
penetration and dermal drug delivery.16
In this study, the formation of nanoparticles incorporat-
ing PDA was investigated. PDA-incorporated nanoparticles 
were prepared through ion-complex formation between 
hair dye and poly(γ-glutamic acid) (PGA)/chitosan. The 
physicochemical properties of PDA-incorporated nano-
particles were studied using dynamic light scattering 
(DLS), Fourier-  transform infrared (FT-IR), powder X-ray 
  diffractometry (XRD), and field-emission scanning electron 
microscopy (FE-SEM). Furthermore, the cytotoxicity of 
PDA-incorporated nanoparticles was tested using human 
skin keratinocyte cells.
Materials and methods
Materials
PGA (molecular weight 200,000–500,000 g/mol) was pur-
chased from WakoPure Chem Co (Osaka, Japan). Glycol 
chitosan (GC) was a product of MP Biomedicals, LLC (Santa 
Ana, CA). Propidium iodide (PI) and PDA were purchased 
from Sigma-Aldrich Co (St Louis, MO). Fluorescein isothio-
cyanate (FITC)-annexin V was obtained from Santa Cruz 
Biotechnology, Inc (Santa Cruz, CA).
Preparation of PDA-incorporated 
nanoparticles
PGA was distributed in 5 mL of deionized water and 
  magnetically stirred for 30 minutes. PDA (5–40 mg) 
  dissolved in 2 mL of deionized water was then added to this 
solution and stirred for 30 minutes. GC dissolved in 5 mL 
deionized water was added to this solution, and stirred for 
30 minutes at room temperature. The resulting solutions were 
then   lyophilized or analyzed.
Characterization of PDA-incorporated 
nanoparticles
Particle size of nanoparticles was measured with DLS (DLS-
7000; Otsuka Electronics Co, Osaka, Japan).
FT-IR spectroscopy (FT-IR 8700; Shimadzu, Osaka, 
Japan) was employed for ion-complex formation between 
PDA and polymers. PDA or lyophilized nanoparticles were 
used for analysis.
The morphology of the nanoparticles was observed 
with FE-SEM (S-4700; Hitachi Co Ltd, Tokyo, Japan). 
  Microspheres were placed on double-sided tape attached 
to a graphite surface. Each sample was coated with gold/ 
palladium using an ion sputter (JFC-1100; Jeol Ltd, 
Tokyo, Japan). Coating was done at 20 mA for 4 minutes. 
Observation was done at 15 kV .
XRD diffractograms were employed to analyze crystal-
linity of drug and drug-incorporated nanoparticles using a 
Rigaku D/Max-1200 (Rigaku, Tokyo, Japan) equipped with 
Ni-filtered Cu Kα radiation (40 kV , 20 mA). The conditions 
of powder XRD measurement were as follows:
•	 Data type = binary; goniometer = 1; attachment = 1; scan 
mode = continuous
•	 Mode 2 (R/T) = reflection; scan axis = 2θ/θ
•	 Start angle = 10,000; stop angle = 80,000; scan 
speed = 5000; sampling interval = 0.050; θ angle = 5000; 
2θ angle = 10,000; fixed time = 0.01; full scale = 1000; 
counting unit = CPS; target = Cu
•	 Wavelength, Kα1 = 1.540510; wavelength, Kα2 = 1.544330; 
wavelength, Kα = 1.541780;   wavelength, Kβ = 1.392170
•	 40.0 kV; 20.0 mA
PDA, PGA, GC, and PDA-incorporated nanoparticles 
were used to measure powder XRD. For physical mixture of 
empty nanoparticles and PDA, 90 mg of empty nanoparticles 
was mixed with 10 mg of PDA.
Drug-release study
The drug-release test was as follows: 5 mg of PDA-
incorporated nanoparticles were redistributed in 5 mL of 
phosphate-buffered saline (PBS) (0.1 M, pH 7.4), and then 
this solution was placed in a dialysis tube. This dialysis 
tube was introduced into a 100 mL bottle with 95 mL of 
PBS (0.01 M, pH 7.4). At predetermined time intervals, 
whole media were taken and exchanged with fresh PBS. 
The concentration of released PDA was measured with a 
high performance liquid chromatography (HPLC) system 
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as reported by Hooff et al.17 The Flexar™ HPLC system 
(PerkinElmer, Waltham, MA) consisted of a Solvent 
Manager 5-CH Degasser, an autosampler, a quaternary 
LC pump, a column oven, and an ultraviolet-visible 
detector. Gradient elution was performed as follows: 
elution solvent, 90% methanol with 10% water, and 0.01 
M ammonium hydroxide (pH 9). The gradient was initiated 
at 5% elution solvent for 4.5 minutes, and subsequently 
a linear gradient led to 95% elution solvent in 5 minutes, 
kept for 2 minutes, and brought back to 5% elution 
  solvent in 0.5 minutes. A Luna phenyl-hexyl column from 
Phenomenex (Aschaffenburg, Germany) was kept at 20°C 
for the separation. PDA was monitored at wavelengths of 
240 nm and 310 nm.
Cell culture
For cytotoxicity testing of PDA and PDA-incorporated 
nanoparticles, HaCaT human keratinocyte cell line obtained 
from the Korean Cell Line Bank (Seoul, Korea) was 
maintained in Dulbecco’s modified Eagle’s medium (DMEM) 
medium at 37°C and 5% CO2 atmosphere.
MTT (3-[4,5-dimethylthiazol-2-yl]-2, 
5-diphenyltetrazolium bromide) assay
The medium for cell culture and proliferation inhibition 
assay was DMEM supplemented with 10% fetal bovine 
serum; cells were maintained in this medium in a 5% CO2 
incubator (37°C). The cytotoxicity of PDA and PDA-
incorporated nanoparticles was determined using an MTT 
cell proliferation assay. HaCaT cells were seeded in 96-well 
plates at a density of 1 × 104 cells/well and incubated for 
1 day in a 5% CO2 incubator at 37°C. PDA and PDA-
incorporated nanoparticles in deionized water were then 
diluted with serum-free DMEM media and then added to 
the HaCaT cells. The control was treated with serum-free 
DMEM media. Three days later, cell viability was assayed 
using the MTT colorimetric assay. After the incubation 
period, 30 µL of MTT (5 mg/mL in PBS, pH 7.4) was added 
to each well and incubated for 4 hours. The formazan crys-
tals were then solubilized with DMSO, and the absorbance 
(560 nm test/630 nm reference) was determined using an 
automated computer-linked microplate reader (Molecular 
Device Co, Sunnyvale, CA). Each experimental value was 
the mean of eight wells.
Flow cytometry analysis
Two reagents, PI and FITC-annexin V , were used to identify 
apoptosis and necrosis of HaCaT cells, respectively. Cells 
were treated with various concentrations of PDA and PDA-
incorporated nanoparticles for 24 hours. After that, cells 
were harvested and washed with PBS. The pellets were 
resuspended with binding buffer (HEPES [10 mM 4-(2-
hydroxyethyl)-1-piperazineethanesulfonic acid] pH 7.4, 
150 mM NaCl, 5 mM KCl, 1 mM MgCl2, 1.8 mM CaCl2) 
containing FITC-annexin V (1 µg/mL) and further incubated 
for 30 minutes. Ten minutes prior to termination of incuba-
tion, PI (10 µg/mL) was added to stain necrotic cells under 
dark conditions. Following that, the cells were immediately 
analyzed using a FACScan (Becton Dickinson Biosciences, 
San Jose, CA) flow cytometer.
Results and discussion
Characterization of PDA-incorporated 
nanoparticles
PDA-incorporated nanoparticles were prepared via ion-
complex formation between cationic groups of PDA and 
anionic groups of PGA (see Figure 1). As shown in Figure 1, 
when PGA was added to deionized water, it was not soluble 
in water. However, clear solution was obtained when PDA 
was added. This result might indicate that ion complexes were 
formed between the amine groups of PDA and the carboxyl 
groups of PGA.
Prior to studying its chemical properties, the potential 
of nanoparticle formation was investigated. To investigate 
its colloidal properties, DLS was used to test particle size 
and FE-SEM was used to observe morphology. As shown 
in Figure 2A, the particle size was about 76.9 nm. Further-
more, spherical nanoparticles were observed during FE-SEM 
observation, as shown in Figure 2B. Chemical properties of 
PDA-incorporated nanoparticles were analyzed using FT-IR 
(see Figure 3). As shown in Figure 3, the primary amine 
peak and the carboxylic acid peak appeared for PDA and 
PGA, respectively. Interestingly, the intrinsic carboxylic acid 
peak of PGA was significantly decreased at peak analysis of 
nanoparticles. Furthermore, the primary amine peak of PDA 
was also decreased in its nanoparticles, indicating that ion 
complexes were formed between amine groups of PDA and 
carboxyl groups of PGA.
To reinforce PDA-incorporated nanoparticles, GC was 
added, as shown in Figure 4 (top pictures). Furthermore, 
changes of physicochemical properties were tested relative 
to the changes in PDA content and GC content, as shown in 
Figure 4 and Table 1. As shown in Figure 4, the opaque PGA 
solution became a brown, transparent solution after addition 
of PDA (Figure 4, top-left), indicating that the transparent 
solution was obtained by the formation of nanosized ion  
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complexes. When GC was added, the particle size was 
increased (Table 1), and the nanoparticle solution became 
slightly turbid, as shown in Figure 4 (top-right).
As shown in Figure 5, the free carboxylic acid peak of 
PGA decreased with increase in PDA content, indicating that 
ion complexes between carboxyl groups and amine groups 
were increased and free carboxylic acid was decreased, as 
shown in Figure 6. At a fixed amount of PDA, particle size 
was not significantly changed by variations in the amount of 
GC, as shown in Table 1. The peak of free carboxylic acid of 
PGA also decreased with increasing GC content, indicating 
1. PGA in deionized water.
13
2. PDA was added to this solution.
3. PDA/PGA polyelectrolyte complex.
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Figure 1 Schematic illustrations of PDA-incorporated nanoparticles based on ion-complex formation between PDA and PGA. Weight ratio of PDA/PGA was 20/50 (mg/mg). 
The opaque solution of PGA was readily changed to a transparent solution by addition of PDA.
Abbreviations: PDA, p-phenylenediamine; PGA, poly(γ-glutamic acid).
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Figure 2 Typical particle size (A) and SEM photo (B) of PDA-incorporated PGA 
nanoparticles.
Note: Composition of PDA/PGA is PDA5 in Table 1.
Abbreviations:  PDA,  p-phenylenediamine;  PGA,  poly(γ-glutamic  acid);  SEM, 
scanning electron microscopy.
4000 3500 3000 2000
Wavelength (nm)
PDA5
PGA
PDA
2500 1500 500 1000
Primary amine
Carboxylic acid
Amide I
Amide II
Figure 3 FT-IR analysis of PDA-incorporated nanoparticles.
Notes: PDA and PGA were used as a solid powder, and lyophilized PDA-incorporated 
nanoparticles (PDA5 in Table 1) were used for FT-IR measurement. Carboxylic 
groups of PGA were decreased by complexation with PDA at PDA5 measurement.
Abbreviations:  FT-IR,  Fourier-transform  infrared;  PDA,  p-phenylenediamine; 
PGA, poly(γ-glutamic acid).
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that ion complexes between amine groups of GC and carboxyl 
groups of PGA had increased.
To investigate the physical state of the nanoparticles, 
powder XRD was employed (see Figure 7). As shown in 
Figure 7, PDA had sharp crystalline peaks, while peaks of 
PGA and GC were relatively broad. Interestingly, crystal-
line peaks of PDA disappeared due to ion-complexes with 
PGA and nanoparticle formation, while physical mixtures 
of PDA and PGA still showed both sharp crystalline peaks 
of PDA and broad peaks of PGA. These results indicate that 
ion complexes between PDA, PGA, and GC were formed, 
and no large amount of free drug existed in the complexes 
with PGA. However, as shown in Figure 7, a small amount of 
free drug may have remained when PDA content was 40 mg 
(PDA4 in Table 1 and Figure 7 [arrow]).
Drug release from PDA-incorporated 
nanoparticles
PDA release properties were investigated in vitro (see 
Figure 8). As shown in Figure 8A, PDA was continuously 
released over 1 week. PDA release rate increased with 
escalating PDA content. These results may be due to PDA 
being liberated at higher drug contents and being decom-
plexed easily from the nanocomplexes due to competition 
Table 1 Characterization of PDA-incorporated submicroparticles of PGA/GC complexes
Formulation no. Weight ratio of  
PGA/PDA/GC (mg)a
Drug contents  
(%, w/w)
Particle size (nm) Statusb
Intensity average Weight average Number average
PDA1 50:5:5 8.3     253.8 ± 108.5 242.3 ± 78.5 230.2 ± 61.8 +
PDA2 50:10:5 15.4 336.2.4 ± 105.5 313.4 ± 90.3 280.9 ± 81.2 +
PDA3 50:20:5 26.7 554.3 ± 130.5 536.4 ± 121.2 465.7 ± 110.8 ++
PDA4 50:40:5 42.1     689.6 ± 121.4 680.0 ± 115.8 523.5 ± 98.7 ++
PDA5 50:10:0 16.7     121.3 ± 60.9 117.9 ± 58.7   76.9 ± 42.0 –
PDA6 50:10:5 15.4     312.5 ± 103.7 290.6 ± 93.6 262.4 ± 63.7 +
PDA7 50:10:10 14.3     320.7 ± 96.7 298.9 ± 102.8 278.6 ± 82.6 ++
PDA8 50:10:20 12.5     328.7 ± 150.9 295.6 ± 121.3 281.8 ± 102.9 +++
Notes: aFinal volume of nanoparticle solution was adjusted to 10 mL; bfine distribution (+, small amount of aggregates; ++, moderate amount of aggregates; +++, significant 
amount of aggregates or precipitation).
Abbreviations: GC, glycol chitosan; PDA, p-phenylenediamine; PGA, poly(γ-glutamic acid).
Figure 4 Photos of the PDA-incorporated nanoparticles. Photo in top-left box is of ion complexes of PDA-incorporated PGA nanoparticles: PDA/PGA weight ratio (w/w) 
(a) 50/5; (b) 50/10; (c) 50/20; and (d) 50/40. The top-right box is of nanoparticles after addition of GC, and the bottom photo is of PDA-incorporated nanoparticles.
Note: The composition of PDA/PGA/GC is illustrated in Table 1.
Abbreviations: GC, glycol chitosan; PDA, p-phenylenediamine; PGA, poly(γ-glutamic acid).
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with each other. As shown in Figure 8B, the PDA release 
rate was also increased by the addition of GC. These results 
indicated that the increase in the amount of amine groups 
may enhance competition in the ion complexes with car-
boxylic acid, and this fact may increase release rate. For 
all samples, the initial burst release was observed until 
6 hours, after which time, the PDA release rate was relatively   
sustained.
At the next step, formulation PDA2 (same as PDA6) was 
used because the aqueous solution of PDA2 was relatively 
stable compared with the other formulations, and its drug-
release kinetics were relatively sustained.
Cell cytotoxicity of PDA-incorporated 
nanoparticles
To investigate cytotoxicity of PDA and PDA-incorporated 
nanoparticles, HaCaT human skin keratinocyte cells were 
employed, and cytotoxicity was evaluated using MTT cell 
proliferation assay. As shown in Figure 9, cell viability 
4000
PDA5
PDA4
PDA3
PDA2
PDA1
PDA
GC
3500 3000 2000
Wavelength (nm)
2500 1500 500 1000
Figure 5 FT-IR analysis of PDA-incorporated nanoparticles, showing the effect of 
PDA content on the chemical properties of nanoparticles.
Notes: The composition of PDA/PGA/GC is illustrated in Table 1. PDA, PGA, and 
GC were used as a solid powder, and lyophilized PDA-incorporated nanoparticles 
(PDA1–5 in Table 1) were used for FT-IR measurement. As PDA content increased, 
the carboxylic acid peak of PGA gradually decreased.
Abbreviations:  GC,  glycol  chitosan;  FT-IR,  Fourier-transform  infrared;  PDA, 
p-phenylenediamine; PGA, poly(γ-glutamic acid).
4000
PDA8
PDA7
PDA6
PDA5
GC
3500 3000 2000
Wavelength (nm)
2500 1500 500 1000
Figure 6 FT-IR analysis of PDA-incorporated nanoparticles showing the effect of 
GC addition on the chemical properties of nanoparticles.
Notes: The composition of PDA/PGA/GC is illustrated in Table 1. GC was used as a 
solid powder, and lyophilized PDA-incorporated nanoparticles (PDA5–8 in Table 1) 
were used for FT-IR measurement. The carboxylic acid peak of PGA decreased with 
increasing GC content.
Abbreviations:  GC,  glycol  chitosan;  FT-IR,  Fourier-transform  infrared;  PDA, 
p-phenylenediamine; PGA, poly(γ-glutamic acid).
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was decreased in a dose-dependent manner when HaCaT 
cells were exposed to PDA itself. On the other hand, when 
HaCaT cells were exposed to PDA-incorporated nanopar-
ticles, viability of cells was not significantly decreased. 
These results indicated that intrinsic cytotoxicity of PDA 
was   alleviated. Although the reason for these results was not 
clear, the sustained-release properties of the nanoparticles 
might be affected by the alleviated toxicity, and another pos-
sibility is better biocompatibility of PGA/GC nanoparticles 
compared with PDA itself. The mechanistic study of cellular 
  cytotoxicity was investigated using Annexin V staining for 
apoptosis analysis and PI staining for necrosis analysis. 
PDA
PDA1
PDA2
PDA3
PDA4
PDA8
PDA7
PDA6
PDA5
GC
Physical mixture
PGA
10 20 30 40
2 theta (°)
50 60 70 80 10 20 30 40
2 theta (°)
50 60 70 80
Figure 7 XRD analysis of PDA-incorporated nanoparticles.
Notes: The composition of PDA/PGA/GC is illustrated in Table 1. PDA, PGA, and GC were used as a solid powder, and lyophilized PDA-incorporated nanoparticles 
(PDA1–8 in Table 1) were used for XRD analysis. The physical mixture was PGA/PDA (weight ratio = 5:1). PDA itself has sharp crystalline peaks, while nanoparticles showed 
broad peaks for all compositions.
Abbreviations: GC, glycol chitosan; PDA, p-phenylenediamine; PGA, poly(γ-glutamic acid); XRD, X-ray diffractometry.
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As shown in Figure 10, both apoptosis and necrosis at PDA 
treatment was higher than nanoparticle treatment, indicating 
that nanosized ion-complex formation between PDA and 
ionic polymer decreased intrinsic cytotoxicity of PDA.
Discussion
Nanoparticles have been extensively investigated in the 
biomedical, cosmetic, and health industries.7–21 In particu-
lar, cosmetic application of nanoparticles is regarded as the 
best technology to upgrade the performance of cosmetic 
products and to meet the consumer’s needs.19 For example, 
Popov et al showed that potential application of zinc oxide 
or titanium oxide nanoparticles for sunscreen has benefit 
to attenuate ultraviolet light by absorption and scattering.20 
Furthermore, the effect of particle size on the potential of 
titanium oxide nanoparticles as a sunscreen was also reported 
by other researchers.22 Even though intrinsic toxicity was 
problematic,23 ingredients based on nanotechnology in cos-
metic products are known to have no more risk to human 
health than larger-sized counterparts.21
Due to hypersensitivity, allergy reaction, and immune 
response, permanent hair dyes such as PDA and its related 
chemicals have been widely investigated.1–5 Since PDA or 
its related chemicals are used more extensively than oxida-
tive hair dyes, their immune-toxicity, carcinogenesis, and 
genetic toxicity is problematic to human skin keratinocyte 
cells.4,5 Mosley-Foreman et al3 reported that permanent hair 
dye revealed cytotoxicity against human skin keratinocyte 
cells under light irradiation, and no chemical structure-related 
phototoxicity of derivatives of PDA was found.
This current report describes the preparation of PDA-
incorporated nanoparticles using PGA and GC. PDA itself did 
not form nanoparticles in aqueous solutions (data not shown). 
Furthermore, PGA itself did not form nanoparticles, and 
PGA was not clearly dissolved in deionized water, ie, it was 
simply distributed in the deionized water. However, opaque 
PGA solution was readily changed into a transparent solution 
when PDA was added, as shown in Figure 1. Interestingly, 
PGA/PDA mixtures were found to form nanoparticles in the 
aqueous solution based on ion-complex formation between 
anionic groups of PGA and cationic groups of PDA. Since 
the formation of these nanoparticles did not require organic 
solvent or surfactant, nanoparticles based on ion complex 
between PGA and PDA are very interesting. Nanocomplexes 
based on polyelectrolytes between anionic compounds and 
cationic compounds have been extensively investigated by 
several researchers.24–28 Thünemann and Beyermann reported 
that retinoic acid as an anionic compound can form ion 
complexes with cationic polymers such as polyethyleneimine, 
and these complexes are nanosized carriers.24 Furthermore, 
they also reported that another cationic polymer, poly(ethylene 
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Figure  9  Cytotoxicity  of  PDA  and  PDA-incorporated  nanoparticles  (PDA2  in 
Table 1) against HaCaT cells. HaCaT cells (1 × 104 cells) were seeded in 96-well 
plates, and then the cells were exposed to PDA or PDA-incorporated nanoparticles 
for 3 days. The cell viability was assayed using the MTT colorimetric assay.
Abbreviations: MTT, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide; 
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Note: The composition of PDA/PGA/GC is illustrated in Table 1.
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glycol)/poly(L-lysine) block copolymer, was also employed 
to form polyion complex micelles. Jeong et al reported 
that retinoic acid and chitosan can form polyion complex 
micelles via interaction between amine groups of chitosan 
and carboxyl groups of retinoic acid, while chitosan itself 
does not form polymeric micelles.26 In another report, they 
described nanoparticle formation based on ion complexes 
between hyaluronic acid and cisplatin.27 Furthermore, they 
also reported that carboxymethyl (CM) chitosan can form 
nanoparticles via ion-complex formation between carboxyl 
groups of CM chitosan and amine groups of doxorubicin.28 
As shown in Figures 2–7, the results of this present study 
showed that PDA-incorporated nanoparticles can be formed 
by ion complexes between amine groups of PDA and carboxyl 
groups of PGA. The complexes formed nanoparticles of 
small size (,1000 nm) and spherical shape. Furthermore, 
intrinsic cytotoxicity of PDA can be reduced by nanoparticle 
  formation, as shown in Figures 9 and 10. Even though initial 
burst release of PDA was observed, as shown in Figure 8, 
PDA-incorporated nanoparticles showed sustained release 
of PDA over 1 week. Even though the reason for the initial 
burst release of PDA up to 6 hours is not clear at this moment, 
we assumed that some of the PDA was weakly attached 
on the surface of the nanoparticles and then these drugs 
were liberated rapidly. Another reason for this initial-burst 
phenomenon might be due to the existence of free drug on 
the surface of the nanoparticles at higher drug concentrations, 
as shown in Figure 7 (arrow, PDA4). However, no drug 
crystalline peaks were observed for the other formulations. 
Therefore, the initial burst release from the nanoparticles 
must be due to the weak interaction between the drug and the 
polymer at the nanoparticle surface rather than the existence 
of free drug. White et al reported that intermittent exposure 
to low-concentration PDA can be equivalent to a single, 
higher-dose exposure.29 The authors of this present paper 
suggest that PDA-incorporated nanoparticles may reduce 
intrinsic toxicity of PDA and enhance potential application 
in the cosmetic industry.
Conclusion
PDA-incorporated nanoparticles were prepared based on 
ion-complex formation between cationic groups of PDA 
and anionic groups of PGA. To reinforce PDA/PGA ion 
complexes, GC was added. PDA-incorporated nanoparticles 
are small in size (,100 nm), and morphological observations 
showed spherical shapes. FT-IR spectra showed the carboxy-
lic acid peak of PGA decreased with increasing PDA content, 
indicating that ion complexes were formed between carboxyl 
groups of PGA and amine groups of PDA. XRD showed 
intrinsic crystalline peaks of PDA completely disappeared 
when nanoparticles were formed by ion complexes between 
PDA, PGA, and GC, indicating that PDA was complexed 
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Figure 10 Flow cytometry analysis of PDA and PDA-incorporated nanoparticles (PDA2 in Table 1) against HaCaT cells. FITC-annexin V (Annexin V) and PI were used for 
apoptosis and necrosis of cells, respectively. Apoptosis or necrosis of cells were analyzed using a FACScan (Becton Dickinson Biosciences, San Jose, CA) flow cytometer.
Abbreviations: FITC, fluorescein isothiocyanate; NP, PDA-incorporated nanoparticles; PDA, p-phenylenediamine; PI, propidium iodide.
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with PGA and no free drug existed in the formulation. The 
drug-release experiment showed an initial burst release of 
PDA and then continuous release over 1 week. Cytotoxicity of 
PDA-incorporated nanoparticles against HaCaT human skin 
keratinocyte cells was lower than PDA alone. Furthermore, 
PDA-incorporated nanoparticles showed reduced apoptosis 
and necrosis reaction in HaCaT cells.
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